Basic artificial intelligence is already incorporated into several premium echocardiography systems. This example is from the Philips Epiq, which can take 3-D datasets and the AI automatically identifies and segments the cardiac anatomy. It then extracts the best images for each of the standard views for an echocardiogram to eliminate variation between operators. The next generation echo AI software will pull in data from the electronic medical records and imaging data to offer suggested diagnoses.
Feature | Artificial Intelligence | Ross Upton
How Will Artificial Intelligence Impact Healthcare?

Artificial Intelligence has a multitude of impacts on our daily lives, from recommending movies based upon your Netflix ...

Home May 07, 2019
Home
Videos | Structural Heart
VIDEO: Tracking Transcatheter Valve Outcomes in the STS-ACC TVT Registry

John Carroll, M.D., FACC, FSCAI, director of interventional cardiology and co-director of the Cardiac and Vascular ...

Home May 06, 2019
Home
Philips Azurion Clarity angiography system in the hybrid cath lab at Henry Ford Hospital.
360 Photos | 360 View Photos
360 Degree View of the Main Hybrid Cath Lab at Henry Ford Hospital

This is a 360 degree image showing the main hybrid cath lab at Henry Ford Hospital in Detroit, which is used for most of ...

Home May 06, 2019
Home
FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic
Technology | Leads Implantable Devices
FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic

Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad MRI SureScan left heart lead. Paired with Medtronic quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead is the only active-fixation left heart lead, according to the company, and is designed for precise lead placement and stability. The lead will be commercially available in the U.S. in summer 2019.

Home May 06, 2019
Home
According to the National Association of County and City Health Officials, only 33 percent of the organizations plan against cybersecurity threats and initiate patient identity protection protocols.
Feature | Cybersecurity | Maxim Chernyak
How to Protect Health Data With Security Testing Automation

As the National Association of County and City Health Officials state, healthcare breaches remained to be costly and ...

Home May 06, 2019
Home
Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor
News | Implantable Cardiac Monitor (ICM)
Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor

Abbott announced the launch of a new, smarter heart monitor for better arrhythmia detection — positive news for people at risk for irregular heartbeats. Now with CE Mark in Europe and U.S. Food and Drug Administration (FDA) clearance, the next-generation Confirm Rx insertable cardiac monitor (ICM), a paperclip-sized implantable device, combines smartphone connectivity and continuous, remote monitoring to track unpredictable heart rhythm problems for fast and accurate diagnosis.

Home May 06, 2019
Home
Illustration showing the self-expanding deployment of the Boston Scientific Vici venous stent in the iliofemoral vein.
Technology | Venous Therapies
FDA Clears Boston Scientific Vici Venous Stent to Treat Deep Venous Blockages

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for ...

Home May 06, 2019
Home
Tafamidis meglumine (Vyndaqel) is one of two new drugs cleared by the FDA for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis (Vyndamax) capsules for the treatment of the cardiomyopathy.
Technology | Heart Failure
FDA Clears New Treatments for Cardiomyopathy Caused by Transthyretin Mediated Amyloidosis

May 6, 2019 — The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis ...

Home May 06, 2019
Home
Bioprinting research from the lab of Rice University bioengineer Jordan Miller featured a proof-of-principle — a scale-model of a lung-mimicking air sac with airways and blood vessels that never touch yet still provide oxygen to red blood cells.
News | Medical 3-D Printing
New Technique Allows More Complicated 3-D Bioprinting

Bioengineers have cleared a major hurdle on the path to 3-D printing replacement organs with a breakthrough technique for bioprinting tissues. The new innovation allows scientists to create exquisitely entangled vascular networks that mimic the body's natural passageways for blood, air, lymph and other vital fluids.

Home May 03, 2019
Home
An example of a cardiac computed tomography angiography (CTA) perfusion exam showing iodine contrast mapping in the myocardium, which is used as a surrogate for blood perfusion.
Podcast | CT Angiography (CTA)
PODCAST: Gianluca Pontone Discusses the Current State Of CT Cardiac Perfusion Imaging

A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino ...

Home May 03, 2019
Home
Cath lab staff working as a team to prepare for a procedure at Presbyterian Medical Center Cardiac Cath Lab, Charlotte N.C. Pictured are Barry Horsey RCIS, Emily Luna RN, RCIS, Adam Martin RCIS, Caleadia Jessup RN.
Feature | Cardiovascular Business | Ruben Filimonczuk, RCES, AS-PMD
Taking The Heart Team Staffing Business Seriously

One of the most promising areas for innovation in healthcare is to be found in the workforce – both in hiring and ...

Home May 03, 2019
Home
Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease
News | Cardiovascular Surgery
Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease

Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published online in The Annals of Thoracic Surgery.

Home May 03, 2019
Home
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.
Feature | ECG | Sanket Solanki
ECG Industry Blooms With Innovative Devices and New Methods

Technology has made its way into the healthcare sector and brought a drastic transformation. Detection of heart ...

Home May 03, 2019
Home
Khaldoon Alaswad, M.D., clearing a chronic total occlusion (CTO) in the cath lab at Henry Ford Hospital.
Podcast | Chronic Total Occlusion (CTO)
PODCAST: How to Treat CTOs and Complex PCI Cases With Khaldoon Alaswad, M.D.

A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital in Detroit on ...

Home May 03, 2019
Home
Concept Medical Inc. Granted Breakthrough Device Designation for MagicTouch Sirolimus Coated Balloon
News | Drug-Eluting Balloons
Concept Medical Inc. Granted Breakthrough Device Designation for MagicTouch Sirolimus Coated Balloon

Concept Medical Inc. (CMI) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for MagicTouch, its sirolimus drug-coated balloon (DCB) catheter, for the treatment of coronary in-stent restenosis (ISR).

Home May 02, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now